Combination therapy with methylprednisolone, rituximab, and tofacitinib in antimelanoma differentiation‐associated 5 gene dermatomyositis with rapidly progressive interstitial lung disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Combination therapy with methylprednisolone, rituximab, and tofacitinib in antimelanoma differentiation‐associated 5 gene dermatomyositis with rapidly progressive interstitial lung disease

Published:2024-03-12 Issue:2 Volume:4 Page:122-125
ISSN:2767-1410
Container-title:Rheumatology & Autoimmunity
language:en
Short-container-title:Rheumatology & Autoimmunity

Author:

Manghani Mona¹,Lim Weiyen²,Chai Gin Tsen³,Lim Xin Rong¹,Chua Choon Guan¹

Affiliation:

1. Department of Rheumatology, Allergy and Immunology Tan Tock Seng Hospital Singapore City Singapore

2. Department of Preventative and Population Medicine Tan Tock Seng Hospital Singapore City Singapore

3. Department of Respiratory Medicine Tan Tock Seng Hospital Singapore City Singapore

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/rai2.12112

Reference9 articles.

1. Single-cell profiling reveals distinct adaptive immune hallmarks in MDA5+ dermatomyositis with therapeutic implications

2. P153 Characteristics of anti-melanoma differentiation-associated gene 5 positive dermatomyositis in Singapore

3. Clinical Correlations With Dermatomyositis-Specific Autoantibodies in Adult Japanese Patients With Dermatomyositis

4. Dermatomyositis With Anti-MDA5 Antibodies: Bioclinical Features, Pathogenesis and Emerging Therapies

5. Tofacitinib for refractory interstitial lung diseases in anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP